Koyfin Home > Directory > Health Care > ANI Pharma Inc > Total Debt / EBITDA

ANI Pharma Inc Total Debt / EBITDA Chart (ANIP)

ANI Pharma Inc annual/quarterly Total Debt / EBITDA from 2012 to 2020.
  • ANI Pharma Inc Total Debt / EBITDA for the quarter ending June 06, 2020 was $6m a 53.99% increase of 3m year over year
  • ANI Pharma Inc Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $6m a 59.49% increase of 4m year over year
  • ANI Pharma Inc Annual Total Debt / EBITDA for 2019 was $3m a 21.77% increase of 1m from 2018
  • ANI Pharma Inc Annual Total Debt / EBITDA for 2018 was $2m a -43.50% decrease of -1m from 2017
  • ANI Pharma Inc Annual Total Debt / EBITDA for 2017 was $4m a 39.22% increase of 1m from 2016
Other Ratios Metrics:
  • ANI Pharma Inc Total Debt / Capital for the quarter ending December 12, 2018 was $48m a -10.11% decrease of -5m year over year
  • ANI Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -404.03% decrease of -2m year over year
  • ANI Pharma Inc Total Debt / Equity for the quarter ending December 12, 2018 was $93m a -21.52% decrease of -20m year over year
View Chart On Koyfin

Quarterly ANIP Total Debt / EBITDA Data

06/2020$6m
03/2020$16m
12/2019$10m
09/2019$3m
06/2019$2m
03/2019$2m
12/2018$2m
09/2018$3m
06/2018$3m
03/2018$3m

Annual ANIP Total Debt / EBITDA Data

2019$3m
2018$2m
2017$4m
2016$2m
2015$3m
2014$4m
2012$3m
2011$37m